• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail

Return to search Page to restart searchReturn to Orphan Designation Search PageReturn to Search Page
Trade Name:n/a
Date Designated: 10-31-2012
Orphan Designation:Prophylaxis following documented or suspected exposure to marburg virus
Orphan Designation Status: Designated
FDA Orphan Approval Status:Not FDA Approved for Orphan Indication
Sarepta Therapeutics, Inc.
215 First Street
Suite 7
Cambridge, MA 02142

The sponsor address listed is the last reported by the sponsor to OOPD.